I
Isabelle C. Van Gelder
Researcher at University Medical Center Groningen
Publications - 351
Citations - 56632
Isabelle C. Van Gelder is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 74, co-authored 326 publications receiving 44197 citations. Previous affiliations of Isabelle C. Van Gelder include University of Groningen & University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'.
Zbigniew Kalarus,Georges H. Mairesse,Adam Sokal,Giuseppe Boriani,Beata Sredniawa,Ruben Casado Arroyo,Rolf Wachter,Gerrit Frommeyer,Vassil Traykov,Nikolaos Dagres,Gregory Y.H. Lip,Lucas V.A. Boersma,Petr Peichl,Dobromir Dobrev,Alan Bulava,Carina Blomström-Lundqvist,Natasja M.S. de Groot,Renate B. Schnabel,Frank R. Heinzel,Isabelle C. Van Gelder,Corrado Carbuccichio,Dipen Shah,Lars Eckardt +22 more
Journal ArticleDOI
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks,Tatjana S. Potpara,Nikolaos Dagres,Elena Arbelo,Jeroen J. Bax,Carina Blomström-Lundqvist,Giuseppe Boriani,Manuel Castellá,Gheorghe-Andrei Dan,Polychronis Dilaveris,Laurent Fauchier,Gerasimos Filippatos,Jonathan M. Kalman,Mark La Meir,Deirdre A. Lane,Jean-Pierre Lebeau,Maddalena Lettino,Gregory Y.H. Lip,Fausto J. Pinto,G. Neil Thomas,Marco Valgimigli,Isabelle C. Van Gelder,Bart P. van Putte,Caroline L Watkins +23 more
Journal ArticleDOI
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.
Andreas Metzner,Anna Suling,Axel Brandes,Axel Brandes,Günter Breithardt,A. John Camm,Harry J.G.M. Crijns,Lars Eckardt,Arif Elvan,Andreas Goette,Laurent M. Haegeli,Hein Heidbuchel,Josef Kautzner,Karl-Heinz Kuck,Luis Mont,A Andre Ng,Lukasz Szumowski,Sakis Themistoclakis,Isabelle C. Van Gelder,Panos E. Vardas,Karl Wegscheider,Stephan Willems,Paulus Kirchhof +22 more
TL;DR: In EAST-AFNET 4, the clinical benefit of early, systematic rhythm control therapy was achieved using variable treatment patterns of antiarrhythmic drugs and atrial fibrillation ablation, applied within guideline recommendations as mentioned in this paper.
Journal ArticleDOI
Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study
Anne H Hobbelt,Joylene E. Siland,Bastiaan Geelhoed,Pim van der Harst,Hans L. Hillege,Isabelle C. Van Gelder,Michiel Rienstra +6 more
TL;DR: The clinical, biomarker, and genetic predictors of development of specific types of incident AF in a community‐based cohort are found and the genetic background seems to play a more important role than modifiable risk factors in self‐terminating AF.
Journal ArticleDOI
Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm—A CIBIS II analysis
TL;DR: Heart rate has been associated with prognosis in patients with heart failure with reduced ejection fraction (HFREF) and sinus rhythm; whether this also holds true in Patients with atrial fibrillation (AF) is unknown.